Raise your Query
Hi! Simply click below and type your query.
Our experts will reply you very soon.
Hi! Simply click below and type your query.
Our experts will reply you very soon.
| Pharmacopoeia | IP/IH |
| Molar Mass | 464.825 g/mol |
| CAS ID | 284461-73-0 |
| Formula | C21H16ClF3N4O3 |
| Click to view more | |
Preferred Buyer From
| Location | All Countries Except India |
Product Details
Sorafenib, is a kinase inhibitor drug approved for the treatment of primary kidney cancer, advanced primary liver cancer, FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.
